Christopher B Miller, BS^1*, Charles G Mullighan, MBBS(Hons), MSc, MD¹, Xiaoping Su, PhD^1*, Jing Ma, PhD^2*, Michael Wang, PhD^2*, Jinghui Zhang, Ph.D.^3*, Richard T Williams, MD, PhD⁴ and James R. Downing, MD^1*

¹Pathology, St. Jude Children's Research Hospital, Memphis, TN
²Hartwell Center, St. Jude Children's Research Hospital, Memphis, TN
³National Cancer Institute, Rockville, MD
⁴Oncology, St. Jude Children's Research Hospital, Memphis, TN

Cihangir Duy^1*, Lars Klemm^1*, Rahul Nahar^1*, Peter van Essen^1*, Mieke Sprangers^2*, Yong-mi Kim^1*, Eugene Park^1*, Giovanni Martinelli^3*, Nora Heisterkamp^1*, Wolf-Karsten Hofmann, MD^4*, Hassan Jumaa^5* and Markus Muschen²

¹Childrens Hospital Los Angeles, University of Southern California, Leukemia Research Program, Los Angeles, CA
²Leukemia Research Program, Childrens Hospital Los Angeles, Los Angeles, CA
³Department of Hematology/Oncology “L. and A. Serągnoli”, University of Bologna, Italy
⁴MILE Study Group, on Behalf of European LeukemiaNet (ELN, WP13), Munich, Germany
⁵Molecular Immunology, Max-Planck-Institute for Immunology, Freiburg, Germany

Cihangir Duy^1*, J. Jessica Yu^2*, Leandro Cerchietti^3*, Lars Klemm^1*, Rahul Nahar^1*, Yong-mi Kim^1*, Nora Heisterkamp^1*, Giovanni Martinelli^4*, Wolf-Karsten Hofmann, MD^5*, Hassan Jumaa^6*, Ari Melnick³, B. Hilda Ye, PhD^7* and Markus Muschen⁸

¹Childrens Hospital Los Angeles, University of Southern California, Leukemia Research Program, Los Angeles, CA
²Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
³Hematology and Oncology Division, Weill Cornell Medical College, New York, NY
⁴Department of Hematology/Oncology “L. and A. Serągnoli”, University of Bologna, Italy
⁵MILE Study Group, on Behalf of European LeukemiaNet (ELN, WP13), Munich, Germany
⁶Molecular Immunology, Max-Planck-Institute for Immunology, Freiburg, Germany
⁷Dept. of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
⁸Leukemia Research Program, Childrens Hospital Los Angeles, Los Angeles, CA

Erich Piovan, MD, PhD^*, Masumichi Saito, PhD^*, Katia Basso, PhD^*, Urban Novak, MD^*, Qiong Shen^*, Laura Pasqualucci, MD^* and Riccardo Dalla-Favera

Institute for Cancer Genetics, Department of Pathology and Genetics & Development, Columbia University, New York, NY

Cyrus Khandanpour, MD¹, Ehssan Sharif-Askari, PhD^1*, Paul Jolicoeur, MD, PhD^2*, Ulrich Duehrsen, MD^3* and Tarik Moroy, PhD¹

¹Institut de recherches cliniques de Montreal - IRCM, Montreal, QC, Canada
²Molecular Biology, Instit. de recherches cliniques de Montreal, Montreal, QC, Canada
³University Hospital Essen, Essen, Germany

Pedro Jose Real, PhD^1*, Valeria Tosello, PhD^1*, Teresa Palomero, PhD², Mireia Castillo, MD^3*, Catherine Sawai^4*, Maria Luisa Sulis, MD^5*, Jules P.P. Meijerink^6*, Giuseppe Basso, MD^7*, Iannis Aifantis, PhD, MSC⁸, Carlos Cordon-Cardo, MD^9* and Adolfo A. Ferrando, MD, PhD¹

¹Institute for Cancer Genetics, Columbia University, New York, NY
²Institute for Cancer Genetics, New York, NY
³Pathology Department, Columbia University, New York
⁴Pathology Department, NYU Cancer Institute, New York, NY
⁵Pediatric Oncology, Columbia University, New York, NY
⁶Dept. of Pediatric Oncology/Hematology, ErasmusMC Rotterdam-Sophia Children's Hospital, Rotterdam, Netherlands
⁷Dept. Pediatrics, University of Padova, Padova, Italy
⁸Pathology, NYU School of Medicine, New York, NY
⁹Pathology Department, Columbia University, New York, NY

Urban Novak^1*, Andrea Rinaldi^2*, Ivo Kwee^2*, Subhadra V. Nandula^1*, Paola M.V. Rancoita^3*, Mara Compagno^1*, Michaela Cerri^4*, Davide Rossi^4*, Vundavalli V. Murty^1*, Emanuele Zucca^2*, Gianluca Gaidano^4*, Riccardo Dalla-Favera¹, Laura Pasqualucci^1*, Francesco Bertoni² and Govind Bhagat¹

¹Institute for Cancer Genetics, Department of Pathology and Genetics & Development, Columbia University, New York, NY
²Oncology Institute of Southern Switzerland, Laboratory of Experimental Oncology and Lymphoma Unit, Bellinzona, Switzerland
³Istituto Dalle Molle di Studi sull'Intelligenza Artificiale, Manno, Switzerland
⁴Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Evripidis Gavathiotis, Ph.D.^1*, Motoshi Suzuki, Ph.D.^2*, Marguerite L. Davis^1*, Kenneth Pitter^1*, Gregory H. Bird, PhD^1*, Samuel G. Katz, MD, PhD^1*, Ho-Chou Tu^3*, Hyungjin Kim^3*, Emily Cheng, M.D., Ph.D.^3*, Nico Tjandra, Ph.D.^2* and Loren D. Walensky, MD, PhD¹

¹Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital Boston, Harvard Medical School, Boston, MA
²Laboratory of Molecular Biophysics, National Heart, Lung, and Blood Institute, Bethesda, MD
³Division of Molecular Oncology, Washington University in St. Louis School of Medicine, Saint Louis, MO